BABY Insider Trading Activity and SEC Form 4 Filings
BABY insider trading summary
No open-market insider purchases or sales of Natus Medical Inc (BABY) have been reported on SEC Form 4 in the past 12 months.
Latest BABY insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 1, 2019 | Ken Ludlum | Director | Sell | $403K (12,632 @ $31.94) |
| Jul 31, 2019 | Austin Francis Noll III | Executive VP and CCO | Sell | $623K (20,000 @ $31.14) |
| Jun 11, 2019 | Ken Ludlum | Director | Sell | $104K (4,250 @ $24.41) |
| May 31, 2019 | Ken Ludlum | Director | Sell | $149K (6,000 @ $24.84) |
| May 21, 2019 | Dong Chune Christopher Chung | VP of Medical Affairs | Sell | $13K (500 @ $26.64) |
| May 17, 2019 | Dong Chune Christopher Chung | VP of Medical Affairs | Sell | $79K (3,000 @ $26.28) |
| May 10, 2019 | Ken Ludlum | Director | Sell | $197K (7,515 @ $26.28) |
| May 2, 2019 | Robert A Gunst | Director | Sell | $54K (2,000 @ $26.92) |
| May 1, 2019 | Robert A Gunst | Director | Sell | $108K (4,000 @ $26.88) |
| Apr 30, 2019 | Robert A Gunst | Director | Sell | $53K (2,000 @ $26.25) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.